Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling

Şehmus Tohumeken(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dimitrios Mougiakakos(Otto-von-Guericke-Universität Magdeburg), Rebecca Baur(Friedrich-Alexander-Universität Erlangen-Nürnberg), Regina Jitschin(Friedrich-Alexander-Universität Erlangen-Nürnberg), Konstantinos Panagiotidis(University of Patras), Heiko Bruns(Friedrich-Alexander-Universität Erlangen-Nürnberg), Romy Loschinski(Otto-von-Guericke-Universität Magdeburg), Andreas S. Baur(Friedrich-Alexander-Universität Erlangen-Nürnberg), Simon Völkl(Universitätsklinikum Erlangen), Andréas Mackensen(University Medical Center Freiburg), Andrej Stoll(Friedrich-Alexander-Universität Erlangen-Nürnberg), Martin Böttcher(Otto-von-Guericke-Universität Magdeburg), Martina Braun(Friedrich-Alexander-Universität Erlangen-Nürnberg), Domenica Saul(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cancer Research
June 30, 2020
10.1158/0008-5472.can-20-0024
Cited by 55

Related Papers

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
|Nature|2023|296
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
|The Lancet Haematology|2019|247
The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts
|Immunity|2021|245
Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells
|Cancer Immunology Immunotherapy|2000|240